Search
                    Utah Paid Clinical Trials
A listing of 1209  clinical trials  in Utah  actively recruiting volunteers for paid trials and research studies in various therapeutic areas.
            1153 - 1164 of 1209
        
                Utah is currently home to 1209 active clinical trials, seeking participants for engagement in research studies. These trials take place at a variety of cities in the state, including Salt Lake City, Murray, Ogden and West Jordan. Whether you're a healthy volunteer interested in paid medical research or someone seeking trials related to a specific condition, the state offers a diverse array of opportunities in your vicinity.
            
                                                Featured Trial
                
                Healthy Participants Needed (Colonoscopy + Cancer Screening)
            
        Recruiting
            
        Earn $325 - $475 in electronic payment card compensation for your time and effort by participating in a clinical study to develop a blood test that may one day help screen for colon cancer. Take a quick quiz to see if you qualify.
    
    
                            Conditions: 
                                    
        
            
                        Healthy
                    
                                    
                        Healthy Volunteers
                    
                                    
                        Healthy Subjects
                    
                                    
                        Healthy Volunteer
                    
                                    
                        Healthy Participants
                    
                                    Featured Offer
                
                Lose Weight with GLP-1 Medications
            
        Recruiting
            
        Policy Lab has partnered with OnlineSemaglutide.org to offer trusted access to semaglutide and other GLP-1 medications, including generic alternatives to Ozempic® and Wegovy®. 
GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $50 off your first program with code policy-lab-50.
    GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $50 off your first program with code policy-lab-50.
                            Conditions: 
                                    
        
            
                        Overweight
                    
                                    
                        Overweight and Obesity
                    
                                    
                        Obesity
                    
                                    
                        Weight Loss
                    
                                    
                        Morbid Obesity
                    
                                    Featured Trial
                
                Stroke Clinical Study
            
        Recruiting
            
        A clinical study for people that suffer with Stroke
    
    
                            Conditions: 
                                    
        
            
                        Stroke
                    
                                    Featured Trial
                
                Chronic Kidney Disease (CKD) Clinical Study
            
        Recruiting
            
        A clinical study for people that suffer with Chronic Kidney Disease (CKD)
    
    
                            Conditions: 
                                    
        
            
                        Chronic Kidney Disease (CKD)
                    
                                    Featured Trial
                
                Ischemic heart disease (IHD) Clinical Study
            
        Recruiting
            
        A clinical study for people that suffer with Ischemic heart disease (IHD)
    
    
                            Conditions: 
                                    
        
            
                        Ischemic heart disease (IHD)
                    
                                    
                
                                    Acceptability and Feasibility of Transcranial Magnetic Stimulation (TMS) for Depression in Multiple Sclerosis
                                
            
            
        Recruiting
                            
            
                The goal of this single-arm, observational pilot study is to learn about the safety, feasibility, preliminary efficacy of TMS for the treatment of depression in people with MS. Participants will receive outpatient TMS treatment over the course of 5-6 weeks. Participants will complete validated questionnaires and exams before, during, and after treatment.             
        
        
    Gender:
                ALL
            Ages:
                Between 18 years and 75 years
            Trial Updated:
                03/22/2024
            
            Locations: University of Utah Health, Salt Lake City, Utah         
        
        
            
        
    
                
                                    Intermountain Inpatient Bilirubin Decision Accuracy Study Using Smartphone-based Measurements by Picterus Jaundice Pro
                                
            
            
        Recruiting
                            
            
                The goal of this project is to evaluate the performance of Picterus Jaundice Pro in an American population, including preterm and term newborns and pre- and post- phototherapy.             
        
        
    Gender:
                ALL
            Ages:
                Between 12 hours and 192 hours
            Trial Updated:
                03/21/2024
            
            Locations: Intermountain Health, Salt Lake City, Utah         
        
        
            Conditions: Neonatal Jaundice
        
            
        
    
                
                                    Post-Market Feasibility Study of the Tenon Medical CATAMARAN™ SI Joint Fusion System
                                
            
            
        Recruiting
                            
            
                The purpose of this study is to evaluate the outcomes of patients with sacroiliac joint pain treated with the CATAMARAN SI Joint Fusion System.             
        
        
    Gender:
                ALL
            Ages:
                Between 18 years and 75 years
            Trial Updated:
                03/18/2024
            
            Locations: St. George Orthopedic Spine, Saint George, Utah         
        
        
            Conditions: Sacroiliac Joint Disruption, Degenerative Sacroiliitis
        
            
        
    
                
                                    Cerebral Hemorrhage Risk in Hereditary Hemorrhagic Telangiectasia
                                
            
            
        Recruiting
                            
            
                This study is one of the three projects of an NIH Rare Disease Clinical Research Consortium. A "consortium" is a group of centres sharing information and resources to perform research. The consortium research focuses on brain blood vessel malformations in three different rare diseases.
The focus of this specific study is on Hemorrhagic Telangiectasia (HHT).
HHT is a condition characterized by blood vessel malformations, called telangiectasia and arteriovenous malformations (AVMs), occurring in...  Read More             
        
        
    Gender:
                ALL
            Ages:
                All
            Trial Updated:
                03/04/2024
            
            Locations: University of Utah, Salt Lake City, Utah         
        
        
            Conditions: Hereditary Hemorrhagic Telangiectasia
        
            
        
    
                
                                    Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort
                                
            
            
        Recruiting
                            
            
                Enroll-HD is a longitudinal, observational, multinational study that integrates two former Huntington's disease (HD) registries-REGISTRY in Europe, and COHORT in North America and Australasia-while also expanding to include sites in Latin America. More than 30,000 participants have now enrolled into the study. With annual assessments and no end date, Enroll-HD has built a large and rich database of longitudinal clinical data and biospecimens that form the basis for studies developing tools and b...  Read More             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                02/26/2024
            
            Locations: University of Utah, Salt Lake City, Utah         
        
        
            Conditions: Huntington's Disease
        
            
        
    
                
                                    Observational Registry to Assess the Durability of Effect of CXL in Patients With Corneal Ectasia After Refractive Surgery
                                
            
            
        Recruiting
                            
            
                The objectives of this post market registry are to evaluate the safety and durability of treatment effect up to 3 years following cross-linking performed with Photrexa Viscous (riboflavin 5'- phosphate in 20% dextran ophthalmic solution), Photrexa (riboflavin 5'- phosphate ophthalmic solution), and the KXL System in patients with corneal ectasia following refractive surgery.             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                02/22/2024
            
            Locations: Hoopes Vision, Draper, Utah         
        
        
            Conditions: Corneal Ectasia
        
            
        
    
                
                                    Development and Testing of a Pediatric Cervical Spine Injury Risk Assessment Tool
                                
            
            
        Recruiting
                            
            
                Cervical spine injuries (CSI) are serious, but rare events in children. Spinal precautions (rigid cervical collar and immobilization on a longboard) in the prehospital setting may be beneficial for children with CSI, but are poorly studied. In contrast, spinal precautions for pediatric trauma patients without CSI are common and may be associated with harm. Spinal precautions result in well-documented adverse physical and physiological sequelae. Of substantial concern is that the mere presence of...  Read More             
        
        
    Gender:
                ALL
            Ages:
                18 years and below
            Trial Updated:
                02/21/2024
            
            Locations: Primary Children's Medical Center, Salt Lake City, Utah         
        
        
            Conditions: Cervical Spine Injury
        
            
        
    
                
                                    A Study to Investigate Leramistat in Patients With IPF
                                
            
            
        Recruiting
                            
            
                To compare the effect of daily oral dosing of leramistat over 12 weeks with placebo in participants aged 40 years or older with idiopathic pulmonary fibrosis (IPF).             
        
        
    Gender:
                ALL
            Ages:
                40 years and above
            Trial Updated:
                02/16/2024
            
            Locations: University of Utah - PPDS, Salt Lake City, Utah         
        
        
            Conditions: Idiopathic Pulmonary Fibrosis
        
            
        
    
                
                                    ETNA-MS Device Validation Study
                                
            
            
        Recruiting
                            
            
                The overarching goal of this research protocol is to validate the effectiveness of Innodem's ETNA-MS device in informing clinicians on the disability status of Multiple Sclerosis (MS) patients. Effectiveness of the device will be assessed by the level of agreement between the EDSS estimated by the device and the actual scores measured by the neurologist in-person assessments.             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                02/05/2024
            
            Locations: Rocky Mountain MS Research Group, Salt Lake City, Utah         
        
        
            Conditions: Multiple Sclerosis
        
            
        
    
                
                                    Mindful Waiting Room
                                
            
            
        Recruiting
                            
            
                This will be a single-site, five-arm, parallel group randomized control trial involving patients seeking integrative healthcare. Four different styles of 5-minute, audio-recoded mindfulness practices delivered in the clinic waiting room will be compared with a 5-minute audio-recording about integrative healthcare.
A secondary sub-analysis will investigate the most effective mindfulness practice style for patients presenting at the clinic with elevated anxiety, depression, or pain.             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                02/05/2024
            
            Locations: University of Utah, Salt Lake City, Utah         
        
        
            Conditions: Anxiety State, Depressive State, Pain, Nausea, Fatigue, Cancer
        
            
        
    
                
                                    The Acute Burn ResUscitation Multicenter Prospective Trial
                                
            
            
        Recruiting
                            
            
                This is a prospective randomized multi-center study which will compare acute fluid resuscitation using a colloid strategy (LR + 5% Albumin) to a crystalloid strategy (LR alone), in adults with an acute burn involving at least 25% of their total body surface area.             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                01/31/2024
            
            Locations: University of Utah Health, Salt Lake City, Utah         
        
        
            Conditions: Burn Injury
        
            
        
    
                
                                    Validation of Early Prognostic Data for Recovery Outcome After Stroke for Future, Higher Yield Trials
                                
            
            
        Recruiting
                            
            
                VERIFY will validate biomarkers of upper extremity (UE) motor outcome in the acute ischemic stroke window for immediate use in clinical trials, and explore these biomarkers in acute intracerebral hemorrhage. VERIFY will create the first multicenter, large-scale, prospective dataset of clinical, transmagnetic stimulation (TMS), and MRI measures in the acute stroke time window.             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                01/24/2024
            
            Locations: University of Utah Healthcare, Salt Lake City, Utah         
        
        
            Conditions: Stroke, Stroke, Acute, Stroke, Ischemic, Stroke Hemorrhagic
        
            
        
    